MMSI · NASDAQ · STOCK
Merit Medical Systems, Inc.
$91.02
52W $59.74 – $94.75
57/100
$5.44B
37.2
0.49
Is MMSI Bullish or Bearish?
Mixed.
Innellis AI committee rates Merit Medical Systems, Inc. (MMSI) Watch with a composite score of 57/100
, based on 6 analysts with 50% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +2.53 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -17.47 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 32.5% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.20 across 20 articles, 14d) — News
Bear Case
- P/E of 36.9 is moderate-to-rich — Value
- RSI at 93 is in overbought territory — Technical
- Weekly RSI at 89 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 32.5% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
57/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 66%
of 192 Healthcare peers
Value Analyst
neutral
55
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 36.9 is moderate-to-rich
Growth Analyst
bullish
65
/ 100 · Low confidence
Strong, accelerating growth with consistent execution
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− RSI at 93 is in overbought territory
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 32.5% signals elevated volatility
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 20 articles, 14d)
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
93.1
Overbought
MACD Histogram
0.882
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$86.14
Resistance
$93.19
Bollinger %B
0.90
Inside Bands
Price vs Moving Averages
EMA 9
$86.74
Above
EMA 21
$81.75
Above
EMA 50
$75.85
Above
EMA 200
$76.39
Above
Fundamental Analysis
Valuation
48
Profitability
52
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
37.2×
P/B Ratio
3.24×
PEG Ratio
1.80
Dividend Yield
0.00%
52W High
$94.75
52W Low
$59.74
Quality & Growth
ROE
811.0%
ROA
478.4%
Gross Margin
4951.5%
Operating Margin
1275.1%
Revenue Growth YoY
—
Debt / Equity
0.49
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 37.2 (rich relative to a 15-40x range); Price-to-book of 3.2x; PEG ratio of 1.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 8.1%; Return on assets of 4.8%; Net margin of 9.2%; Gross margin of 49.5%; Current ratio of 4.20 (healthy short-term liquidity); Debt-to-equity of 0.49; Free cash flow per share is positive (3.41); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full MMSI Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →